Spero Therapeutics Inc (SPRO) — Financial Flexibility Index
Spero Therapeutics Inc (SPRO) has a Financial Flexibility Index of -0.84x as of December 2025. Free cash flow of $-8.35 Million (operating CF $-8.35 Million minus capex $0.00) represents -1% of total liabilities ($9.90 Million). Also explore SPRO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Spero Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Spero Therapeutics Inc across 11 annual periods. Check asset allocation strategy of Spero Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Spero Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Spero Therapeutics Inc. For the full company profile including market capitalisation, see SPRO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.28x | $-12.62 Million | $-12.62 Million | $9.90 Million | ▼ -250.5% |
| 2024 | -0.36x | $-23.44 Million | $-23.44 Million | $64.42 Million | ▲ +16.7% |
| 2023 | -0.44x | $-32.99 Million | $-32.99 Million | $75.50 Million | ▼ -176.3% |
| 2022 | -0.16x | $-7.73 Million | $-7.73 Million | $48.87 Million | — |
| 2021 | 0.00x | $0.00 | $-64.35 Million | $82.78 Million | ▲ +100.0% |
| 2020 | -4.00x | $-85.72 Million | $-85.87 Million | $21.41 Million | ▼ -153.9% |
| 2019 | -1.58x | $-49.71 Million | $-50.02 Million | $31.53 Million | ▲ +44.3% |
| 2018 | -2.83x | $-37.19 Million | $-39.62 Million | $13.15 Million | ▲ +38.3% |
| 2017 | -4.59x | $-39.08 Million | $-39.11 Million | $8.52 Million | ▼ -20.8% |
| 2016 | -3.80x | $-28.13 Million | $-28.96 Million | $7.41 Million | ▼ -200.9% |
| 2015 | -1.26x | $-9.38 Million | $-9.61 Million | $7.43 Million | — |